Role of nation-wide magnetic resonance imaging in the Danish Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis (DanNORMS) study

Jasmin Merhout; Vanessa Wiggermann; Jeppe Romme Christensen; F.R. Therkildsen; R Vestergaards; Enedino Hernandez-Torres; Sascha Gude; Camilla Gøbel  Madsen; Finn Thorup Sellebjerg; Hartwig R. Siebner

Role of nation-wide magnetic resonance imaging in the Danish Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis (DanNORMS) study

Jasmin Merhout, Vanessa Wiggermann, Jeppe Romme Christensen, F.R. Therkildsen, R Vestergaards, Enedino Hernandez-Torres, Sascha Gude, Camilla Gøbel Madsen, Finn Thorup Sellebjerg, Hartwig R. Siebner

Original language	English
Publication date	Sept 2022
Number of pages	1
Publication status	Published - Sept 2022
Event	Meeting of the Danish Society for Magnetc resonance imaging - Duration: 21 Sept 2022 → 21 Sept 2022

Conference

Conference	Meeting of the Danish Society for Magnetc resonance imaging
Period	21/09/2022 → 21/09/2022

Cite this

Merhout, J., Wiggermann, V., Christensen, J. R., Therkildsen, F. R., Vestergaards, R., Hernandez-Torres, E., Gude, S., Madsen, C. G., Sellebjerg, F. T., & Siebner, H. R. (2022). Role of nation-wide magnetic resonance imaging in the Danish Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis (DanNORMS) study. 1-1. Abstract from Meeting of the Danish Society for Magnetc resonance imaging.

Role of nation-wide magnetic resonance imaging in the Danish Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis (DanNORMS) study. / Merhout, Jasmin ; Wiggermann, Vanessa ; Christensen, Jeppe Romme et al.
2022. 1-1 Abstract from Meeting of the Danish Society for Magnetc resonance imaging.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Merhout, J , Wiggermann, V , Christensen, JR, Therkildsen, FR, Vestergaards, R, Hernandez-Torres, E , Gude, S , Madsen, CG , Sellebjerg, FT & Siebner, HR 2022, 'Role of nation-wide magnetic resonance imaging in the Danish Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis (DanNORMS) study', Meeting of the Danish Society for Magnetc resonance imaging, 21/09/2022 - 21/09/2022 pp. 1-1.

@conference{f2567aae79194ccbacdbda92dcc62720,

title = "Role of nation-wide magnetic resonance imaging in the Danish Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis (DanNORMS) study",

author = "Jasmin Merhout and Vanessa Wiggermann and Christensen, {Jeppe Romme} and F.R. Therkildsen and R Vestergaards and Enedino Hernandez-Torres and Sascha Gude and Madsen, {Camilla G{\o}bel} and Sellebjerg, {Finn Thorup} and Siebner, {Hartwig R.}",

year = "2022",

month = sep,

language = "English",

pages = "1--1",

note = "Meeting of the Danish Society for Magnetc resonance imaging, DSMMR ; Conference date: 21-09-2022 Through 21-09-2022",

}

TY - ABST

T1 - Role of nation-wide magnetic resonance imaging in the Danish Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis (DanNORMS) study

AU - Merhout, Jasmin

AU - Wiggermann, Vanessa

AU - Christensen, Jeppe Romme

AU - Therkildsen, F.R.

AU - Vestergaards, R

AU - Hernandez-Torres, Enedino

AU - Gude, Sascha

AU - Madsen, Camilla Gøbel

AU - Sellebjerg, Finn Thorup

AU - Siebner, Hartwig R.

PY - 2022/9

Y1 - 2022/9

M3 - Conference abstract for conference

SP - 1

EP - 1

T2 - Meeting of the Danish Society for Magnetc resonance imaging

Y2 - 21 September 2022 through 21 September 2022

ER -